Revelation Biosciences, Inc. (REVB) has 17 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Fitzpatrick Sean H mit 1,769,538 Aktien. Weitere bedeutende Anteilseigner sind TYPALDOS ANDREAS und GLAZER CAPITAL, LLC.
In den letzten 12 Monaten haben Insider 15 Transaktionen in REVB Aktien getätigt — 10 Käufe (im Wert von $1.72M) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
REVB Insider-Beteiligungen
Größter Aktionär
Fitzpatrick Sean H
1,769,538 Aktien
Käufe (12 Monate)
10
$1.72M Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Fitzpatrick Sean H |
10 Percent Owner, Officer: Chief Executive Officer |
1,769,538 |
2020-12-31 |
|
| 2 |
Typaldos Andreas |
10 Percent Owner, Officer: Chief Executive Officer |
1,769,538 |
2020-12-31 |
|
| 3 |
Glazer Capital, Llc |
10 Percent Owner |
992,652 |
2021-09-23 |
|
| 4 |
Feis Lawrence |
10 Percent Owner |
746,491 |
2021-11-02 |
|
| 5 |
Rolke James |
Chief Executive Officer |
224,853 |
2026-02-05 |
|
| 6 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
105,348 |
2026-02-05 |
|
| 7 |
Roper Jess |
Director |
12,828 |
2026-02-05 |
|
| 8 |
Carver Jennifer |
Director |
12,758 |
2026-02-05 |
|
| 9 |
Chawla Lakhmir S |
Director |
12,158 |
2026-02-05 |
|
| 10 |
Dobkin David |
Director |
10,000 |
2020-10-09 |
|
| 11 |
Dennis Barry |
Director |
10,000 |
2020-10-09 |
|
| 12 |
Hayes Anthony |
Director |
10,000 |
2020-10-09 |
|
| 13 |
Carson William Howard |
Director |
10,000 |
2021-03-11 |
|
| 14 |
Nicholson Robert D |
Director |
10,000 |
2020-10-09 |
|
| 15 |
Angelides Kimon |
Director |
10,000 |
2020-10-09 |
|
| 16 |
Labelle Curt H |
Director |
6,356 |
2023-04-18 |
|
| 17 |
Tidmarsh George F |
Director |
268 |
2025-02-13 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-02-04 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Steuereinbehalt |
13,100 |
$1.65 |
$21.62K |
| 2026-02-03 |
Rolke James |
Chief Executive Officer |
RSU-Steuereinbehalt |
8,521 |
$1.86 |
$15.85K |
| 2026-02-03 |
Carver Jennifer |
Director |
RSU-Steuereinbehalt |
1,661 |
$1.87 |
$3.11K |
| 2026-02-03 |
Chawla Lakhmir S |
Director |
RSU-Steuereinbehalt |
2,261 |
$1.85 |
$4.18K |
| 2026-02-03 |
Roper Jess |
Director |
RSU-Steuereinbehalt |
1,591 |
$1.85 |
$2.94K |
| 2026-01-08 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Zuteilung |
78,145 |
$0.90 |
$70.33K |
| 2026-01-08 |
Rolke James |
Chief Executive Officer |
RSU-Zuteilung |
532,829 |
$0.90 |
$479.55K |
| 2026-01-08 |
Carver Jennifer |
Director |
RSU-Zuteilung |
41,981 |
$0.90 |
$37.78K |
| 2026-01-08 |
Chawla Lakhmir S |
Director |
RSU-Zuteilung |
41,981 |
$0.90 |
$37.78K |
| 2026-01-08 |
Roper Jess |
Director |
RSU-Zuteilung |
41,981 |
$0.90 |
$37.78K |
| 2025-10-29 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Zuteilung |
390,614 |
$1.28 |
$499.99K |
| 2025-10-29 |
Rolke James |
Chief Executive Officer |
RSU-Zuteilung |
390,614 |
$1.28 |
$499.99K |
| 2025-10-29 |
Carver Jennifer |
Director |
RSU-Zuteilung |
15,625 |
$1.28 |
$20K |
| 2025-10-29 |
Chawla Lakhmir S |
Director |
RSU-Zuteilung |
15,625 |
$1.28 |
$20K |
| 2025-10-29 |
Roper Jess |
Director |
RSU-Zuteilung |
15,625 |
$1.28 |
$20K |
